Scientific Meetings Coverage
Testing the combination of immunotherapy and anti-VEGFR in HCC
Oncologyme
/ Feb 15, 2023
In a phase III study presented by Shukui Qin, the combination of #immunotherapy plus an anti-angiogenic TKI showed effectiveness as...
The effect of Behavoiral graded activities and psychological therapies in managing breast cancer symptoms
Oncologyme
/ Mar 26, 2023
A systematic review and meta-analysis of 33 studies that included 4,330 #breast_cancer patients and was done to compare effectiveness of...
TOPIC-NEC trial
Oncologyme
/ Mar 26, 2023
In the randomized phase III TOPIC-NEC trial, Etoposide and cisplatin (EP) showed comparable efficacy to irinotecan and cisplatin (IE) as...
TRIPLETE trial
Oncologyme
/ Mar 26, 2023
In phase III TRIPLETE Study by GONO group, the intensification of the upfront chemotherapy backbone in combination with #panitumumab did...
TROPICS-2 trial
Oncologyme
/ Feb 15, 2023
In the phase III, TROPICS-2 study presented by Hope Rugo el al, #Sacituzumab_govitecan (SG) significantly improved OS (median 14.4 vs...